Life Sciences and Healthcare COVID-19 Briefings:
OXYGY: Demonstrating Value: The New World of Life Sciences Podcast >
OXYGY: Embrace Digitalization: The New World of Life Sciences Podcast >
OXYGY: From rigid & risk averse to agile & experimental: The New World of Life Sciences Podcast >
OXYGY: What Pharma Supply Chain Should Learn from the COVID-19 Crisis >
UAE: COVID-19: our series of regulatory legislation trackers for the Life Sciences & Healthcare industry >
Australia: While COVID-19 lockdown restrictions ease enforcement of advertising restrictions for therapeutic goods tighten >
UK: Our series of COVID-19 regulatory legislation trackers for the Life Sciences & Healthcare industry >
Australia: Export Restrictions on Health Related Products during COVID-19 >
France: ANSM guidance on Data Protection requirements for on-going trials during COVID-19 >
Australia: response to regulation of medical devices during COVID-19 >
China Imposes New Export Restrictions for COVID-19 Medical Products >
Cross-border: Increased leeway for cooperation between Pharma and Medical Equipment companies during the COVID-19 crisis >
Germany: New legislation to fight pandemic may affect granted patents >
Cross-border: EU guidelines on the exercise of the free movement of workers during COVID-19 crisis >
China: A cure for COVID-19? – Don’t make the claim unless it is true >
UK: Public Health Perspectives >
Spain: "State of alarm" and temporary reduction of workforce >